Invesco Ltd. Alx Oncology Holdings Inc Transaction History

Invesco Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.84 - $17.56 $60,093 - $180,692	10,290 New	10,290 $62,000
Q4 2023 Feb 12, 2024	BUY	$4.81 - $15.38 $1.85 Million - $5.92 Million	385,232 New	385,232 $5.74 Million
Q2 2022 Aug 15, 2022	SELL	$5.89 - $19.46 $3.79 Million - $12.5 Million	-643,487 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$13.65 - $22.06 $185,162 - $299,243	13,565 Added 2.15%	643,487 $10.9 Million
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $2.47 Million - $8.56 Million	115,107 Added 22.36%	629,922 $13.5 Million
Q3 2021 Nov 15, 2021	BUY	$52.51 - $80.91 $26.6 Million - $41.1 Million	507,399 Added 6841.95%	514,815 $38 Million
Q2 2021 Aug 17, 2021	BUY	$52.2 - $75.23 $220,545 - $317,846	4,225 Added 132.4%	7,416 $406,000
Q1 2021 May 17, 2021	BUY	$62.84 - $87.68 $200,522 - $279,786	3,191 New	3,191 $235,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.